Nyvepria – Pegfilgrastim uses, dose and side effects
Nyvepria contains the active substance pegfilgrastim. It is used in patients treated with cytotoxic chemotherapy (drugs that destroy fast-growing cells) to reduce the duration of neutropenia (low neutrophil count , a type of white blood cell ) and to prevent febrile neutropenia (low white blood cell count with concomitant fever) . Nyvepria is intended for adults from the age of 18.
Read More